Biotech · Private company
Soterix Medical
Track this companyFree. Adds Soterix Medical to your Dealase workspace and tells you when its record changes.
Clinical trials113 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- Cognitive ReappraisalPhase 2 · Cocaine Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- HD-tDCS (Soterix Medical, Active)Phase 2 · Chronic AphasiaClinicalTrials.gov · fetched Nov 12, 2026
- HD-tDCS (Soterix Medical, Sham)Phase 2 · Chronic AphasiaClinicalTrials.gov · fetched Nov 12, 2026
- transcranial direct current stimulator (tDCS)Phase 2 · Cocaine Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Ketamine (0.25 mg/kg)Phase 1 · Treatment Resistant Depression (TRD)ClinicalTrials.gov · fetched Nov 12, 2026
- Ketamine (0.5 mg/kg)Phase 1 · Treatment Resistant Depression (TRD)ClinicalTrials.gov · fetched Nov 12, 2026
- Ketamine (0.75 mg/kg)Phase 1 · Treatment Resistant Depression (TRD)ClinicalTrials.gov · fetched Nov 12, 2026
- Soterix Medical mini-CT tDCS stimulatorPhase 1 · Unipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Neuro-navigated Transcranial Magnetic Stimulation (TMS)Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Sham tDCS and MindfulnessUnipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Soterix Medical mini-CT tDCS stimulatorCocaine Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- transcranial direct current stimulation (tDCS) and mindfulness instructionUnipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Transcranial Magnetic StimulationTreatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Transcranial Direct Current Stimulation (tDCS) for Treatment of Substance Use DisorderNA · RECRUITING · started Feb 25, 2026ClinicalTrials.gov NCT07318480 · fetched Nov 12, 2026
- Ketamine Biomarker ValidationPHASE1 · WITHDRAWN · started Dec 20, 2025ClinicalTrials.gov NCT07307768 · fetched Nov 12, 2026
- Transcranial Direct Current Stimulation for DepressionNA · RECRUITING · started Jul 1, 2025ClinicalTrials.gov NCT07042217 · fetched Nov 12, 2026
- SMART Stimulation: Precision Neuromodulation of Cognition in Older AdultsNA · COMPLETED · started Jan 17, 2023ClinicalTrials.gov NCT05377411 · fetched Nov 12, 2026
- The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV StudyNA · RECRUITING · started Jun 1, 2022ClinicalTrials.gov NCT05090267 · fetched Nov 12, 2026
- Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRICOMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT05598931 · fetched Nov 12, 2026
- Virtual Neuro-Navigation System for Personalized Community Based TMSNA · COMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT04956081 · fetched Nov 12, 2026
- Home-administered tDCS for Treatment of DepressionPHASE1 · COMPLETED · started Feb 10, 2021ClinicalTrials.gov NCT04781127 · fetched Nov 12, 2026
- TDCS to Reduce Craving in Cocaine Addiction- Phase 2 StudyPHASE2 · COMPLETED · started Sep 28, 2020ClinicalTrials.gov NCT04994821 · fetched Nov 12, 2026
- TDCS for Cocaine Addiction CravingNA · COMPLETED · started Feb 1, 2019ClinicalTrials.gov NCT03833583 · fetched Nov 12, 2026
- Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center StudyPHASE2 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02540109 · fetched Nov 12, 2026